TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+5.43%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$3.11B
AUM Growth
+$3.11B
(+0.07%)
Cap. Flow
-$18.4M
Cap. Flow
% of AUM
-0.59%
Top 10 Holdings %
Top 10 Hldgs %
35.29%
Holding
188
New
16
Increased
27
Reduced
40
Closed
17
Top Buys
| 1 |
Pfizer
PFE
|
$42.6M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$29.7M |
| 3 |
Moderna
MRNA
|
$22.1M |
| 4 |
Danaher
DHR
|
$17.7M |
| 5 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
$16.4M |
Top Sells
| 1 |
Biogen
BIIB
|
$23.6M |
| 2 |
Exact Sciences
EXAS
|
$21.5M |
| 3 |
CTLT
CATALENT, INC.
CTLT
|
$19.2M |
| 4 |
Cigna
CI
|
$18M |
| 5 |
Dentsply Sirona
XRAY
|
$17.3M |
Sector Composition
| 1 | Healthcare | 96.33% |
| 2 | Real Estate | 2.82% |
| 3 | Industrials | 0.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Stoke Therapeutics
STOK
$1.08B
| – | – | -99,263 | Closed | -$2.53M |
|
177
Stevanato
STVN
$6.28B
| – | – | -137,872 | Closed | -$3.49M |
|
178
Bio-Techne
TECH
$8.5B
| – | – | -5,400 | Closed | -$2.62M |
|
179
Vir Biotechnology
VIR
$686M
| – | – | -81,400 | Closed | -$3.54M |
|
180
West Pharmaceutical
WST
$17.8B
| – | – | -6,240 | Closed | -$2.65M |
|
181
Xenon Pharmaceuticals
XENE
$2.98B
| – | – | -169,030 | Closed | -$2.58M |
|
|
CTLT
182
DELISTED
CATALENT, INC.
CTLT
| – | – | -143,913 | Closed | -$19.2M |
|
|
GMDA
183
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| – | – | -118,142 | Closed | -$463K |
|
|
BCEL
184
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| – | – | -229,372 | Closed | -$1.43M |
|
|
TCRR
185
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| – | – | -235,808 | Closed | -$2.01M |
|
|
TPTX
186
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| – | – | -119,324 | Closed | -$7.93M |
|